Animal Vaccines Market Overview:
Global Animal Vaccines Market is expected to garner $9,159 million by 2022, registering a CAGR of 5.2% during the forecast period 2016 - 2022. Animal vaccines control the transmission diseases, thus providing protection to animal and human health, which is essential considering the public dependency on animals. Animals serve as an important source of food, meat, milk, protein, and other commercial products such as leather and wool. Most commonly used veterinary vaccines include rabies vaccines, foot & mouth diseases vaccines, and equine influenza virus vaccines, which prevent the transmission of infectious agents by mimicking the naturally acquired immunity. Constant development of vaccines is essential with rise in emergence of different animal diseases. Increase in pet ownership has significantly accelerated the growth of this market.
Global Animal Vaccines Market Segmentation
The animal vaccines market is segmented on the basis of product type, animal type, and geography. By product type, the market is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. Based on animal type, it is classified into companion animals, cattle, pigs, poultry, and sheep. The companion animals segment is subsegmented into dogs, cats, and others. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The animal vaccines market is growing at a steady pace due to increase in pet ownership in developed countries and rise in number of cattle & poultry in developing countries. Furthermore, rise in investment for R&D of vaccines, which inhibit the growth of antibiotic-resistant organisms boosts the market growth. For instance, in August 2016, Elanco invested two-thirds of the budget for foodanimal unit to develop vaccines and reduce the use of antibiotics. Moreover, rise in demand for animal vaccines has led to the emergence of multiple new vaccines. For instance, Cevac IBron a new vaccine was launched by Ceva in February 2017 that prevents against infectious bronchitis virus (IBV).
The key players profiled in this report include Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, and Anicon Labor GmbH.
Other players operating in the market are Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, and Arko Laboratories, Ltd.
Global Animal Vaccines Market Revenue, By Geography
Asia-Pacific possesses high market potential for animal vaccines due to increase in pet ownership and rise in incidence of various zoonotic diseases. Moreover, ongoing research on innovative vaccine production technology has increased due to high demand for animal-based food products and companion animals. In addition, increase in investments in animal healthcare companies has improved the production of innovative vaccines.
Saudi Arabia Animal Vaccines Market, 2014-2022 ($Million)
The animal vaccines market in Saudi Arabia is projected to grow at a high CAGR of 7.3% during the forecast period. In addition, the U.S. is a mature market for the animal vaccines, as it holds maximum share in the patent registration for animal vaccines. However, Asia-Pacific is experiencing fast-paced growth in terms of production and development of animal vaccines.
Animal Vaccines Market Key Benefits
- The report provides an extensive analysis of the current trends and highlights the market potential from 2014 to 2022, in terms of value.
- The market scenario is comprehensively analyzed with respect to the product type and animal type.
- Comprehensive analysis of the patents is provided to determine the prevailing opportunities.
- Recent developments, key manufacturers, and shares are listed in this report to analyze the competitive scenario of the market.
- In-depth geographical analysis helps to understand the regional market, which assists in strategic business planning.
Animal Vaccines Market Key Segments
- Attenuated Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- Conjugate Vaccines
- Recombinant Vaccines
- DNA Vaccines
By Animal Type
- Companion Animals
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- Rest of LAMEA